800 Participants Needed

Prostate Cancer Screening Education for Prostate Cancer

ET
Overseen ByErika Trapl, PhD
Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: Case Comprehensive Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The purpose of this research is to test intervention strategies that encourage and support Black or African American men who are 40 and older to complete prostate cancer screening, and specifically to complete a prostate-specific antigen (PSA) test.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Education at Community Outreach Screening Event for prostate cancer?

Research shows that educational programs and community outreach can improve understanding of prostate cancer, lead to earlier diagnosis, and enhance patient participation in treatment decisions. These approaches have been successful in increasing knowledge and screening rates in medically underserved communities.12345

Is the prostate cancer screening education program safe for humans?

The research articles reviewed do not provide specific safety data for the prostate cancer screening education program, but they focus on education and awareness, which are generally considered safe activities.15678

How does the prostate cancer screening education treatment differ from other treatments for prostate cancer?

This treatment is unique because it focuses on educating communities, especially underserved ones, about prostate cancer screening through various methods like community events and navigators, rather than using medical interventions. It aims to increase awareness and informed decision-making, which is different from traditional medical treatments that focus on direct medical intervention.15689

Research Team

ET

Erika Trapl, PhD

Principal Investigator

Case Comprehensive Cancer Center

Eligibility Criteria

This trial is for Black or African American individuals who are 40 years old or older, have a prostate gland, and haven't had a PSA test in the last year. They must be able to consent to the study and speak English. Those who've had their prostate removed can't join.

Inclusion Criteria

Self-identify as Black or African American
English speaking
I have never had a PSA test or it's been over a year since my last one.
See 3 more

Exclusion Criteria

I have had surgery to remove my prostate.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Recruitment and Intervention

Participants are recruited and receive one of three intervention strategies: education and passive navigation, education and active navigation, or education and active navigation with community-based outreach.

4 months
Community-based visits and outreach events

Follow-up

Participants are monitored for PSA test completion and provide feedback on their screening experience.

4 months
1 follow-up visit (in-person or virtual)

Long-term Follow-up

Participants are encouraged to follow up with a primary care physician for routine care.

10 months

Treatment Details

Interventions

  • Education at Community Outreach Screening Event
  • Education by Community Navigator
  • Passive Education
Trial Overview The study tests different ways of educating about prostate cancer screening: one-on-one guidance from community navigators, education at community events, and passive educational materials. The goal is to see if these methods increase PSA testing rates.
Participant Groups
3Treatment groups
Experimental Treatment
Group I: Education and Passive NavigationExperimental Treatment1 Intervention
This arm receives barber-led education and access to a resource website. Barbers will encourage clients to access the screening website. Other study materials will also be located within the shop. The resource website will be accessible via QR code that will encourage potential participants to complete a Prostate Cancer Knowledge and Risk Assessment questionnaire.
Group II: Education and Active Navigation with Community Based OutreachExperimental Treatment3 Interventions
This arm adds the community navigator and a community outreach screening event. Case Comprehensive Cancer Center Community Outreach and Engagement will offer barber shops an onsite PSA screening event.
Group III: Education and Active NavigationExperimental Treatment2 Interventions
This arm includes all interventions of the first arm plus the addition of a community navigator. The community navigator will be onsite to assist in information delivery and navigation to resources and encourage the completion of the Screener through the QR code. The community navigator will help participants connect with a primary care provider to continue with all preventive healthcare recommendations.

Education at Community Outreach Screening Event is already approved in United States for the following indications:

🇺🇸
Approved in United States as Community Outreach Screening Event for:
  • Prostate Cancer Screening Education

Find a Clinic Near You

Who Is Running the Clinical Trial?

Case Comprehensive Cancer Center

Lead Sponsor

Trials
472
Recruited
33,400+

Findings from Research

A public seminar on prostate cancer organized by a committee of healthcare professionals revealed a strong demand for education and support among attendees, indicating a gap in current resources for patients and caregivers.
Feedback from participants highlighted a significant interest in ongoing support groups and additional educational forums, suggesting that such initiatives could greatly benefit those affected by prostate cancer.
Prostate disease patients: planning services to meet their coping needs.Anderson, PJ., Dowell, CJ., Fairbrother, G., et al.[2015]
Community outreach events for colorectal cancer (CRC) screening can motivate individuals to seek or obtain screening, with 26.7% of participants who were due for screening doing so within 3 months after attending an event.
However, many attendees were already compliant with screening guidelines, indicating that these events may not effectively reach those most in need of screening, particularly if priority audiences are not specifically targeted.
Results from an Evaluation of the Georgia Colorectal Cancer Control Program's Community Education and Outreach Events, 2013.Woodruff, RC., Hermstad, A., Honeycutt, S., et al.[2019]
The one-day workshop for cancer patients focused on enhancing communication with healthcare providers, covering critical topics like diagnosis, treatment options, and difficult conversations about end-of-life care.
Participants primarily attended to share their experiences rather than to learn specific communication skills, highlighting the importance of peer support and shared understanding in navigating cancer care.
Teaching patients how to improve communication with their health care providers: a unique workshop experience.Fisch, M., Zichi Cohen, M., Rutledge, C., et al.[2015]

References

Prostate disease patients: planning services to meet their coping needs. [2015]
Results from an Evaluation of the Georgia Colorectal Cancer Control Program's Community Education and Outreach Events, 2013. [2019]
Teaching patients how to improve communication with their health care providers: a unique workshop experience. [2015]
Managing the low-socioeconomic-status prostate cancer patient. [2021]
Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men. [2019]
Promoting informed decision making: evaluating a community-based prostate health awareness program. [2006]
Prostate cancer survivors as community health educators: implications for informed decision making and cancer communication. [2021]
Psychosocial and educational intervention trials in prostate cancer. [2019]
Male cancer awareness: impact of an employee education program. [2015]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security